Are Patients Suffering From DSPS Show Compromising in Everyday Functions and Abilities Before Handling the Disorder?
NCT02962037 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2016-11-11
Summary
The purpose of this study is to determine whether the known treatment for DSPS also improve the cognitive ability and mood of the patients.
Conditions
- Delayed Sleep Phase Syndrome
Interventions
- OTHER
-
Melatonin and light therapy
Sponsors & Collaborators
-
Lilach Kemer
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2017-08-31
- Completion
- 2017-11-30
More Related Trials
-
Cognitive and Drug Therapy for Drug-Resistant Depression
NCT00000376 ·Status: COMPLETED ·Phase: NA
-
Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
NCT00232167 ·Status: TERMINATED ·Phase: PHASE3
-
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Sleep Deprivation
NCT05893173 ·Status: COMPLETED
-
An 8-week, Open-label Study to Evaluate the Effect of Sertraline on Polysomnogram in Depressive Patients With Insomnia
NCT01032434 ·Status: COMPLETED ·Phase: NA
-
STILDEP: Zolpidem in Depressive and Dysthimic Patients
NCT00292734 ·Status: COMPLETED ·Phase: PHASE4
-
Fluoxetine vs. Brief Psychotherapy for Major Depression
NCT00714779 ·Status: COMPLETED ·Phase: NA
-
Treatment of Mild and Subthreshold Depressive Disorders
NCT00226642 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
NCT00705003 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
NCT00125957 ·Status: COMPLETED ·Phase: PHASE3
-
Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome
NCT00149825 ·Status: COMPLETED ·Phase: PHASE2
-
SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
NCT00114374 ·Status: TERMINATED ·Phase: PHASE3
-
Interpersonal Psychotherapy for Treatment Resistant Depression
NCT01896349 ·Status: UNKNOWN ·Phase: NA
-
Study of Fluoxetine in Adults With Autistic Disorder
NCT00027404 ·Status: COMPLETED ·Phase: NA
-
Treatments for Psychogenic Nonepileptic Seizures (NES)
NCT00159965 ·Status: COMPLETED ·Phase: PHASE4
-
Citalopram to Enhance Cognition in HD
NCT00271596 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Citalopram Treatment in Acute Stroke
NCT01937182 ·Status: COMPLETED ·Phase: PHASE2
-
Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD)
NCT03310281 ·Status: COMPLETED ·Phase: NA
-
The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
NCT00581009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion
NCT00090831 ·Status: COMPLETED
-
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
NCT00048854 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
NCT00704379 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
NCT00357097 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Sertraline on Depression in Parkinson's Disease
NCT01437189 ·Status: COMPLETED ·Phase: NA
-
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103 ·Status: COMPLETED ·Phase: PHASE2
-
Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes
NCT00177424 ·Status: TERMINATED ·Phase: PHASE4